PortalPublikationenInflammatory lesions of the peritoneum mimic carcinomatosis ...

Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab.

Standard

Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab. / Rüssel, Jörn; Stein, Alexander; Behrmann, Curd; Hauptmann, Steffen; Krummenerl, Patrick; Schmoll, Hans-Joachim; Arnold, Dirk.

in: J CLIN ONCOL, Jahrgang 29, Nr. 22, 22, 2011, S. 644-646.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Rüssel, J, Stein, A, Behrmann, C, Hauptmann, S, Krummenerl, P, Schmoll, H-J & Arnold, D 2011, 'Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab.', J CLIN ONCOL, Jg. 29, Nr. 22, 22, S. 644-646. <http://www.ncbi.nlm.nih.gov/pubmed/21606410?dopt=Citation>

APA

Rüssel, J., Stein, A., Behrmann, C., Hauptmann, S., Krummenerl, P., Schmoll, H-J., & Arnold, D. (2011). Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab. J CLIN ONCOL, 29(22), 644-646. [22]. http://www.ncbi.nlm.nih.gov/pubmed/21606410?dopt=Citation

Vancouver

Rüssel J, Stein A, Behrmann C, Hauptmann S, Krummenerl P, Schmoll H-J et al. Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab. J CLIN ONCOL. 2011;29(22):644-646. 22.

Bibtex

@article{0db8d36cfae84416bb87ae878d152706,
title = "Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab.",
keywords = "Diagnosis, Differential, Humans, Male, Middle Aged, Treatment Outcome, Clinical Trials, Phase II as Topic, Tomography, X-Ray Computed, Neoplasm Staging, Chemotherapy, Adjuvant, Gastrectomy, Infusions, Intravenous, Postoperative Period, Intraoperative Period, Infusions, Parenteral, Adenocarcinoma/drug therapy/secondary/surgery/*therapy, Antibodies, Bispecific/administration & dosage/*adverse effects, Antineoplastic Combined Chemotherapy Protocols/administration & dosage/*adverse effects, Carcinoma/*diagnosis, Peritoneal Neoplasms/*diagnosis/secondary, Peritonitis/chemically induced/*diagnosis, Stomach Neoplasms/drug therapy/pathology/surgery/*therapy, Diagnosis, Differential, Humans, Male, Middle Aged, Treatment Outcome, Clinical Trials, Phase II as Topic, Tomography, X-Ray Computed, Neoplasm Staging, Chemotherapy, Adjuvant, Gastrectomy, Infusions, Intravenous, Postoperative Period, Intraoperative Period, Infusions, Parenteral, Adenocarcinoma/drug therapy/secondary/surgery/*therapy, Antibodies, Bispecific/administration & dosage/*adverse effects, Antineoplastic Combined Chemotherapy Protocols/administration & dosage/*adverse effects, Carcinoma/*diagnosis, Peritoneal Neoplasms/*diagnosis/secondary, Peritonitis/chemically induced/*diagnosis, Stomach Neoplasms/drug therapy/pathology/surgery/*therapy",
author = "J{\"o}rn R{\"u}ssel and Alexander Stein and Curd Behrmann and Steffen Hauptmann and Patrick Krummenerl and Hans-Joachim Schmoll and Dirk Arnold",
year = "2011",
language = "English",
volume = "29",
pages = "644--646",
journal = "J CLIN ONCOL",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "22",

}

RIS

TY - JOUR

T1 - Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab.

AU - Rüssel, Jörn

AU - Stein, Alexander

AU - Behrmann, Curd

AU - Hauptmann, Steffen

AU - Krummenerl, Patrick

AU - Schmoll, Hans-Joachim

AU - Arnold, Dirk

PY - 2011

Y1 - 2011

KW - Diagnosis, Differential

KW - Humans

KW - Male

KW - Middle Aged

KW - Treatment Outcome

KW - Clinical Trials, Phase II as Topic

KW - Tomography, X-Ray Computed

KW - Neoplasm Staging

KW - Chemotherapy, Adjuvant

KW - Gastrectomy

KW - Infusions, Intravenous

KW - Postoperative Period

KW - Intraoperative Period

KW - Infusions, Parenteral

KW - Adenocarcinoma/drug therapy/secondary/surgery/therapy

KW - Antibodies, Bispecific/administration & dosage/adverse effects

KW - Antineoplastic Combined Chemotherapy Protocols/administration & dosage/adverse effects

KW - Carcinoma/diagnosis

KW - Peritoneal Neoplasms/diagnosis/secondary

KW - Peritonitis/chemically induced/diagnosis

KW - Stomach Neoplasms/drug therapy/pathology/surgery/therapy

KW - Diagnosis, Differential

KW - Humans

KW - Male

KW - Middle Aged

KW - Treatment Outcome

KW - Clinical Trials, Phase II as Topic

KW - Tomography, X-Ray Computed

KW - Neoplasm Staging

KW - Chemotherapy, Adjuvant

KW - Gastrectomy

KW - Infusions, Intravenous

KW - Postoperative Period

KW - Intraoperative Period

KW - Infusions, Parenteral

KW - Adenocarcinoma/drug therapy/secondary/surgery/therapy

KW - Antibodies, Bispecific/administration & dosage/adverse effects

KW - Antineoplastic Combined Chemotherapy Protocols/administration & dosage/adverse effects

KW - Carcinoma/diagnosis

KW - Peritoneal Neoplasms/diagnosis/secondary

KW - Peritonitis/chemically induced/diagnosis

KW - Stomach Neoplasms/drug therapy/pathology/surgery/therapy

M3 - SCORING: Journal article

VL - 29

SP - 644

EP - 646

JO - J CLIN ONCOL

JF - J CLIN ONCOL

SN - 0732-183X

IS - 22

M1 - 22

ER -